How Does an Antibody Become a PrecisionAb™ Antibody?Video
For more information, visit http://www.bio-rad.com/CheckoutPrecis... For a primary antibody to be selected as a PrecisionAb Antibody, it must be highly specific, highly sensitive, and pass a rigorous validation process that includes consistent performance from batch to batch. Out of throusands of primary antibodies screened, only a few are admitted into the elite PrecisionAb Antibody category. Try PrecisionAb Antibodies and see how you can generate reproducible data without wasting time and resources on optimization. PrecisionAb Validated Western Blotting Antibodies offer researchers • High specificity and sensitivity – selected for low nonspecific binding, correct target molecular weight, and the strongest signal on a western blot • Reproducible results – stringent QC requirements ensure consistent lot-to-lot performance • Trial size for every antibody (2 applications) - conveniently evaluate western blot performance • Confidence in your data – positive control lysate provided for each antibody; validation protocol included We Are Bio-Rad. Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges. Connect with Bio-Rad Antibodies Online: Website: https://www.bio-rad-antibodies.com/ LinkedIn: https://www.linkedin.com/showcase/bio... Facebook: https://www.facebook.com/BioRadAntibo... Twitter: https://twitter.com/BioRadAbs Pinterest: https://www.pinterest.com/BioRadAbs/ Instagram: @BioRadLabs Snapchat: @BioRadLabs
The All New Affinity ITC - Perfected ITC AutomationVideo
While others have attempted ITC automation, leading to bent syringes and imperfect data, TA Instruments has perfected it with the all new Affinity ITC!
Dr. Jeffrey Trent and Dr. Muhammad Murtaza of TGen, an affiliate of City of Hope, discuss the significance of liquid biopsies in the diagnoses and management of life-threatening diseases.Watch Now
Researchers have traced the origins of relapse in acute myeloid leukemia and identified two distinct stem-cell like populations from which relapse can arise.Watch Now
Richard Eglen Ph.D. of Corning Life Sciences talks 3D cell culture.Watch Now
Professor Awen Gallimore of Cardiff University describes the limitations of current cancer immunotherapy and the role Treg depletion plays.Watch Now